Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05979532

A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk

The current longitudinal (max. 2-year) observational cohort study in 120 lactating mothers and their newborns will make it possible to explore human milk composition across different lactation stages, between different human milk groups, and in relation to maternal, perinatal, infant, and sample characteristics as well as to the microbiota of the infant.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Danone Nutricia Research

Utrecht, 3584CT, Netherlands

Location status: Recruiting

Location contact

M. Visser

PRINCIPAL_INVESTIGATOR

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women in the third trimester of pregnancy (≥28 weeks) who have the intention to provide breastfeeding for at least 6 months post-partum.
  • Age ≥ 18 years.
  • Willingness to provide residual human milk.
  • Living in proximity of NCRU (clinical site in NL).
  • Dutch speaking and reading.
  • Freezer -18°C available.
  • Having mobile phone, tablet, or computer available.
  • Signed informed consent from the subject (pregnant woman).
  • Signed informed consent from the other parent and/or legally acceptable representative, of the unborn baby(s), aged ≥ 18 years.

Exclusion criteria

  • Pregnant women known positive for human immunodeficiency virus (HIV), hepatitis B (HBV), or hepatitis C (HCV).
  • Multiple pregnancy > 2.
  • Incapability of subjects to comply with study protocol as per the judgment of the site staff (e.g. fluency in local language, access to laptop/smartphone devices and internet connection required for data collection).
  • Women (and their unborn baby(s)) with current or intended participation in any other clinical study involving investigational or marketed products.
  • Employees and/or children/family members or relatives of employees of Nutricia Research or the participating site.

Continuation exclusion criteria (after birth)

  • Stillbirth
  • Newborn having any congenital abnormality, chromosomal disorder or severe disease that would prevent the infant from breastfeeding and/or growing normally based on the opinion of a health care professional and/or study physician.
  • No donation of any milk sample within the first 8 weeks postpartum (timepoints week 1, week 1.5, and week 4).

Treatment and study plan

Primary outcomes

  1. Examples of exploratory outcome parameters in this study are the following human milk outcome parameters.

    Time frame: at Day 3 and at Week 1.5, 4, 10, 26, 52, and 104 postpartum.

    Laboratory analyses of Human Milk Oligosaccharides (HMOs), proteins, amino acids, lipids, and fatty acids.

  2. The following exploratory faecal outcome parameter will be analysed if sufficient faecal samples are collected.

    Time frame: at Day 3 and at Week 1.5, 4, 10, 26, 52, and 104 postpartum.

    Laboratory analyses of Infant's faecal microbiome composition.

Study contacts

Contact information is provided by the study sponsor or research team.

Danone Nutricia Research N Research

CONTACT

[email protected]

+31 30 2095 000

Sponsors and collaborators

Lead sponsor

Nutricia Research

Industry

Registry information

Official study title

A Longitudinal Prospective, Observational, Cohort Study in Lactating Mothers and Their Newborns to Further Unravel the Complexity of Human Milk

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Aug 7, 2023
Registry last updated
Mar 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.